Study sheds light on cancer cells affinity with sugarApril 16th, 2008 - 12:56 pm ICT by admin
Washington, April 16 (ANI): Experts at the Duke School of Medicine say that they are apparently close to discerning the secret behind the affinity between cancer cells and sugar.
They say that their research may be useful for scientists in charting a mechanism that may lead to better cancer treatments.
Working under the guidance of Assistant Professor Jeffrey Rathmell in the Duke Department of Pharmacology and Cancer Biology, graduate student Jonathan Coloff found that the tumour cells use glucose sugar as a way to avoid programmed cell death.
While making a presentation at the American Association of Cancer Research Annual Meeting in San Diego on Tuesday, the researchers said that lab experiments showed that tumour cells make use of a protein called Akt to promote glucose metabolism, which in turn regulates a family of proteins critical for cell survival.
In normal cells, the removal of growth factors that regulate metabolism and cell survival leads to loss of glucose uptake and metabolism and cell death.
However, cancer cells maintain glucose metabolism and resist cell death, even when deprived of growth factors.
Coloff and his colleagues studied how Akt might affect these processes.
The researchers introduced a cancer-causing form of Akt, known as myrAkt, into cells that depend on growth factor to survive.
The mutant form of Akt allowed cells to maintain glucose usage, and survive even when no growth factors were present, allowing them to bypass a normal safeguard used by cells to prevent cancer development.
The researchers pointed out that the death of normal cells after the removal of growth factors is partly accomplished by two proteins called Mcl-1 and Puma.
However, they added, the cancer-causing version of Akt prevents the two proteins from accomplishing that tasks, allowing the cell to survive when it should not.
The team also observed that the withdrawal of glucose from the environment rendered Akt unable to maintain regulation of the key targeted proteins Mcl-1 and Puma, and the cells died.
Akts dependence on glucose to provide an anti-cell-death signal could be a sign of metabolic addiction to glucose in cancer cells, and could give us a new avenue for a metabolic treatment of cancer, said Dr. Rathmell, in whose lab the experiments were conducted. (ANI)
- New strategy to fight cancer drug resistance discovered - Jun 21, 2010
- Protein study sheds light on insulin response and cancer cell growth - Nov 06, 2010
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
- Proteins' absence causes diabetes, rheumatoid arthritis - Sep 10, 2012
- Cell suicide can trigger cancer growth - Aug 02, 2010
- Protein that contributes to ulcerative colitis revealed - Apr 02, 2011
- 'Body's natural cell-suicide program can fuel tumour development' - Aug 01, 2010
- Protein that makes local bladder cancer invasive found - May 15, 2010
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- Ultraviolet light 'helps skin cancer cells survive, proliferate' - Dec 08, 2010
- Fish oil may hold key to leukaemia cure - Dec 23, 2011
- Potential therapeutic target for breast cancer identified - Apr 06, 2011
- Slowing down prostate cancer by starving its cells - Nov 03, 2011
- Cutting calorie intake starves brain cancer - Jul 25, 2010
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
Tags: affinity, assistant professor, biology graduate student, cancer biology, cancer cells, cancer development, cancer research, cancer treatments, cell death, cell survival, duke department, duke school, glucose metabolism, glucose uptake, growth factors, lab experiments, professor jeffrey, proteins, school of medicine, tumour cells